Skip to content

ClinFAST™ - The Business Case for rapid Clinical Trial Drug Product

Drug product manufacturing is often overlooked!

It takes advanced planning to produce on-time, high-quality drug products for clinical trials. Too often, this is an afterthought, and then there is a rush to get it done.

What are the potential issues:

  • Small volume open fill/finish slots are hard to come by (they just don't make enough money for big CMOs)
  • Competing with larger, commercial-scale projects for an open slot at another CMO
  • Waiting for 6-12 months for an open slot due to lack of capacity
  • The result could be missing your clinical trial slot costs your company significant money and thus delays your potential launch

What's the solution:
Selkirk Pharma's ClinFAST™ is our proprietary process for expediting small-volume clinical fill/finish manufacturing and delivering clinical trial material in a fraction of the typical timeframe of large CMOs.

Click on this link to download more information on Selkirk Pharma's ClinFAST™

 

About Selkirk Pharma

 

Selkirk Pharma (www.selkirkpharma.com) is a world-class sterile fill/finish CMO in Spokane, Washington, USA. We are a key partner for companies that need a partner with a reliable, high-yield, US-based contract manufacturing organization (CMO). Selkirk Pharma was purpose-built by fill/finish industry veterans for on-time, in-full, sterile fill/finish GMP manufacturing of injectable drug products. You can count on our industry-leading processes, technologies, and support that reduce production bottlenecks, address product shortages, and onshore pharmaceutical manufacturing. Selkirk’s promise is the reliable delivery of your high-quality products. We offer best-in-class liquid vial filling in our Bausch + Ströbel VarioSys® fill line. We offer full Analytical and microbial services.

Want to learn more, visit our website at www.selkirkpharma.com, Virtually tour our facility, or reach out to our BD team at bd@selkirkpharma.com

 

Please complete the form below if you have any feedback on this article.